新闻
SGRY
--
0.00%
--
SVB Leerink 开始对评级为跑赢大盘的手术合作伙伴进行报道,宣布目标价为 50 美元
SVB Leerink analyst Whit Mayo initiates coverage on Surgery Partners (NASDAQ:SGRY) with a Outperform rating and announces Price Target of $50.
Benzinga · 1天前
医疗机构将获得超过 250 亿美元的 COVID-19 救济资金
Healthcare organizations are set to receive $25 billion in COVID-19 relief from the funds allocated by Congress last year to cover losses from the pandemic, The Wall Street Journal reports. In several spending
Seekingalpha · 09/10 15:20
Avantor, Inc. (AVTR) 创下新高:还有运行的空间吗?
Zacks.com · 09/10 13:15
Cowen & Co. 开始对具有市场表现评级的手术合作伙伴进行报道,宣布目标价为 50 美元
Cowen & Co. analyst Gary Taylor initiates coverage on Surgery Partners (NASDAQ:SGRY) with a Market Perform rating and announces Price Target of $50.
Benzinga · 09/10 09:24
三年前投资 Surgery Partners(纳斯达克股票代码:SGRY)的人上涨了 219%
Surgery Partners, Inc. ( NASDAQ:SGRY ) shareholders might be concerned after seeing the share price drop 25% in the...
Simply Wall St. · 09/09 13:31
5只医疗服务股对抗行业逆风
Zacks.com · 09/01 13:31
Bain Capital Investors LLC 收购 Surgery Partners Inc、Aveanna Healthcare Holdings Inc 和出售
GuruFocus News · 08/24 19:38
Hood River Capital Management LLC 收购 Fortress Transportation and Infrastructure Investo,...
GuruFocus News · 08/17 18:38
Park Avenue Institutional Advisers LLC 购买景顺高级贷款 ETF、SPDR Blackstone Senior ...
GuruFocus News · 08/16 21:38
4 周内下跌 26.4%,这就是你应该购买手术合作伙伴 (SGRY) 的原因
Surgery Partners (SGRY) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Zacks · 08/11 14:00
First Trust Small Cap Growth AlphaDEX ETF (FYC) 是否应该在您的投资雷达上?
Zacks.com · 08/11 10:20
德克萨斯州州长敦促医院推迟择期手术后 MedTech 股票暴跌
The shares of medical device makers have come under pressure in morning hours after Texas Governor Greg Abbott encouraged the hospitals to consider postponing certain elective medical procedures to make
Seekingalpha · 08/10 15:54
Surgery Partners (SGRY) 报告第二季度盈亏平衡收益
Surgery Partners (SGRY) delivered earnings and revenue surprises of 100.00% and -0.33%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 08/04 13:15
手术合作伙伴:第二季度收益洞察
  Shares of Surgery Partners (NASDAQ:SGRY) fell 0.7% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 100.00% over the past year to $0.00, which beat the estimate of ($0.20).
Benzinga · 08/04 12:11
Surgery Partners Q2 每股收益 0.00 美元超过预期的 (0.20) 美元,销售额为 5.4330 亿美元,超过预期的 5.383 亿美元
Surgery Partners (NASDAQ:SGRY) reported quarterly sales of $543.30 million which beat the analyst consensus estimate of $538.30 million by 0.93 percent. This is a 45.00 percent increase over sales of $374.70 million the
Benzinga · 08/04 11:48
BRIEF-Surgery Partners Inc Posts Qtrly Loss Per Share $0.39
reuters.com · 08/04 11:38
Surgery Partners 每股收益减少 0.09 美元,高于收入
Surgery Partners (NASDAQ:SGRY): Q2 GAAP EPS of -$0.39 misses by $0.09. Revenue of $543.3M (+45.0% Y/Y) beats by $9.88M. Press Release
Seekingalpha · 08/04 11:28
Surgery Partners, Inc. 公布 2021 年第二季度业绩
Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the second quarter ended June 30, 2021.
GlobeNewswire · 08/04 11:00
Surgery Partners 公布的第二季度亏损更小,收入增加;重申 21 财年指引
MT Newswires · 08/04 09:30
Trustcore Financial Services, Llc 购买 FT Cboe Vest US ...
GuruFocus News · 08/02 16:38
微牛提供丰富的实时SGRY股票新闻,让你可以通过多个平台了解SGRY股票行情最新动态,这些免费的Surgery Partners新闻可以帮助你做出明智投资。
SGRY 简况
Surgery Partners Inc是一家医疗保健服务公司。该公司运营三个业务部门:外科设施服务部、辅助设施服务部和光学服务部。该公司的外科设施服务部从事运营门诊手术中心(ASCs)和外科医院业务,包括麻醉服务。该公司的外科手术设施主要提供各种专科的非紧急外科手术服务,包括胃肠道(GI)、普通外科、眼科、骨科和疼痛管理。辅助设施服务部包括诊断实验室、专业药房和多专业执业医师。该公司的医师业务包括根据管理服务协议拥有和运营的医师业务。该公司的光学服务部包括一个光学实验室和一个光学产品采购组织。